DPC 4/SMAD 4 in non-pancreatic tumors with frequent LOH 18q21 and in hematological malignancies

International Journal of Oncology

Volumn 10, Issue 2, 1997, Pages 257-260

  Verbeek, Walter ^a,c   Spirin, Konstantin ^a   Hatta, Yoshihiro ^a   Miller, Carl ^a   Kawamata, Norihiko ^a   Takeuchi, Seisho ^a   Koike, Michiaki ^a   Asou, Hiroya ^a   Simpson, Jean F ^b   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

breast cancer; DPC 4 SMAD 4 gene; hematological malignancies; non small cell lung cancer; osteogenic sarcoma; prostate cancer

Indexed keywords

ARTICLE; BREAST CANCER; HETEROZYGOSITY; HUMAN; HUMAN CELL; LEUKEMIA; LUNG CANCER; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

EID: 12644296993     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.2.257     Document Type: Article

References (18)

1. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rosenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE: DPC 4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353, 1996.
2. Hahn SA, Hoque ATMS, Moskaluk C, da Costa LT, Schutte M, Rosenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH and Kern SE: Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56: 490-494, 1996.
3. Graff JM, Bansal A and Melton DA: Xenopus Mad proteins tranduce distinct subsets of signals for the TGF β superfamily. Cell 85: 479-487, 1996.
4. Massague J: TGF β signaling: receptors, tranducers, and Mad proteins. Cell 85: 947-950, 1996.
5. Riggins GJ, Thiagaligam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JKV, Markovitz SD, Kinzler K and Vogelstein B: Mad-related genes in the human. Nature Genet 2: 347-348, 1996.
6. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM and Massague J: A human Mad protein acting as a BMP regulated transcriptional activator. Nature 381: 620-623, 1996.
7. Aldaz CM, Chen T, Sahin A, Cunningham J and Bondy M: Comparative alleotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 55: 3976-3981, 1995.
8. Gao X, Honn KV, Grignon D, Sakr W and Chen YQ: Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 53: 2723-2727, 1993.
9. Shiseki M, Kohno T, Nishikawa R, Sameshima Y, Mizogushi H and Yokota J: Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res 54: 5643-5648, 1994.
10. Fong KM, Zimmermann PV and Smith PJ: Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res 55: 220-223, 1995.
11. Thompson AM, Morris RG, Wallace M, Wyllie AH, Steel CM and Carter DC: Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68: 64-68, 1993.
12. Tanaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Tawaguchi N, Kaneko Y, Nakamura Y, Sasaki M and Ishizaki K: Allelotype analysis in osteosarcoma: frequent allelic loss on 3q, 13q, 17p and 18q. Cancer Res 52: 2419-2423, 1992.
13. Orita M, Iwahana H, Kanazawa H, Hayashi K and Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770, 1996.
14. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA, Meltzer PS, Hahn AS and Kern SE: DPC4 gene in various tumor types. Cancer Res 56: 2527-2530, 1996.
15. Nagatake M, Takagi Y, Osada K, Kosaku U, Mitsudomi T, Saji S, Shimokata M, Takahashi T and Takahashi T: Somatic in vivo alterations of the DPC 4 gene at 18q21 in human lung cancers. Cancer Res 56: 2718-2720, 1996.
16. Kim KS, Fan Y, Papadimitrakopoulou V, Clayman G, Hittelman WN, Hong WK, Lotan R and Mao L: DPC 4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res 56: 2519-2521, 1996.
17. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL and Attisano L: MADR2 maps to 18q21 and encodes a TGF β-regulated MAD related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552, 1996.
18. Thiagaligam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JKV, Markowitz S, Hamilton SR, Kem SE, Kinzler KW and Vogelstein B: Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancers. Nature Genet 2: 343-344, 1996.